{"id":1045,"date":"2015-07-01T12:00:04","date_gmt":"2015-07-01T10:00:04","guid":{"rendered":"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/"},"modified":"2015-07-01T12:00:04","modified_gmt":"2015-07-01T10:00:04","slug":"evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc","status":"publish","type":"project","link":"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/","title":{"rendered":"Evolutionary cancer modeling using growth kinetics of drug sensitive\/resistant cells optimizes dosing strategies for EGFR-mutant NSCLC"},"content":{"rendered":"<p>[et_pb_section admin_label=&#8221;section&#8221;][et_pb_row admin_label=&#8221;row&#8221;][et_pb_column type=&#8221;4_4&#8243;][et_pb_text admin_label=&#8221;Projekttitel&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; text_font_size=&#8221;14&#8243; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;]<\/p>\n<h4><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=Evolutionary+cancer+modeling+using+growth+kinetics+of+drug+sensitive%2Fresistant+cells+optimizes+dosing+strategies+for+EGFR-mutant+NSCLC\" target=\"_blank\">Evolutionary cancer modeling using growth kinetics of drug sensitive\/resistant cells optimizes dosing strategies for EGFR-mutant NSCLC<\/a><\/h4>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Autoren&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; text_font_size=&#8221;14&#8243; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;]<\/p>\n<p>Chmielecki J, Foo J, Oxnard G, Hutchinson K, Ohashi K, Somwar R, Wang L,\u00a0 Amato KR, Arcila M,\u00a0 Sos ML, Socci ND, Viale A, de Stanchina E, Ginsberg MS, Thomas RK, Kris MG, Inoue A, Ladanyi M, Miller VA, Michor F, Pao W<\/p>\n<p>[\/et_pb_text][et_pb_text admin_label=&#8221;Journal+Ver\u00f6ffentlichung&#8221; background_layout=&#8221;light&#8221; text_orientation=&#8221;left&#8221; text_font_size=&#8221;14&#8243; use_border_color=&#8221;off&#8221; border_color=&#8221;#ffffff&#8221; border_style=&#8221;solid&#8221;]<\/p>\n<p>Journal: Science Translational Medicine, Vol 3, No 90, doi:10.1126\/scitranslmed.3002356<br \/>Ver\u00f6ffentlichung: 2011<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Journal: Science Translational Medicine, Vol 3, No 90, doi:10.1126\/scitranslmed.3002356<br \/>\nVer\u00f6ffentlichung: 2011<\/p>\n","protected":false},"author":19,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"project_category":[41],"project_tag":[],"class_list":["post-1045","project","type-project","status-publish","hentry","project_category-2011-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Evolutionary cancer modeling using growth kinetics of drug sensitive\/resistant cells optimizes dosing strategies for EGFR-mutant NSCLC - Lung Cancer Group Cologne<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evolutionary cancer modeling using growth kinetics of drug sensitive\/resistant cells optimizes dosing strategies for EGFR-mutant NSCLC - Lung Cancer Group Cologne\" \/>\n<meta property=\"og:description\" content=\"Journal: Science Translational Medicine, Vol 3, No 90, doi:10.1126\/scitranslmed.3002356 Ver\u00f6ffentlichung: 2011\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/\" \/>\n<meta property=\"og:site_name\" content=\"Lung Cancer Group Cologne\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/\",\"url\":\"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/\",\"name\":\"Evolutionary cancer modeling using growth kinetics of drug sensitive\/resistant cells optimizes dosing strategies for EGFR-mutant NSCLC - Lung Cancer Group Cologne\",\"isPartOf\":{\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/#website\"},\"datePublished\":\"2015-07-01T10:00:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.lungcancergroup.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Projects\",\"item\":\"https:\/\/www.lungcancergroup.de\/en\/project\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Evolutionary cancer modeling using growth kinetics of drug sensitive\/resistant cells optimizes dosing strategies for EGFR-mutant NSCLC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.lungcancergroup.de\/en\/#website\",\"url\":\"https:\/\/www.lungcancergroup.de\/en\/\",\"name\":\"Lung Cancer Group Cologne\",\"description\":\"Lungenkrebs Studiengruppe K\u00f6ln\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.lungcancergroup.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evolutionary cancer modeling using growth kinetics of drug sensitive\/resistant cells optimizes dosing strategies for EGFR-mutant NSCLC - Lung Cancer Group Cologne","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/","og_locale":"en_US","og_type":"article","og_title":"Evolutionary cancer modeling using growth kinetics of drug sensitive\/resistant cells optimizes dosing strategies for EGFR-mutant NSCLC - Lung Cancer Group Cologne","og_description":"Journal: Science Translational Medicine, Vol 3, No 90, doi:10.1126\/scitranslmed.3002356 Ver\u00f6ffentlichung: 2011","og_url":"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/","og_site_name":"Lung Cancer Group Cologne","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/","url":"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/","name":"Evolutionary cancer modeling using growth kinetics of drug sensitive\/resistant cells optimizes dosing strategies for EGFR-mutant NSCLC - Lung Cancer Group Cologne","isPartOf":{"@id":"https:\/\/www.lungcancergroup.de\/en\/#website"},"datePublished":"2015-07-01T10:00:04+00:00","breadcrumb":{"@id":"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.lungcancergroup.de\/en\/project\/evolutionary-cancer-modeling-using-growth-kinetics-of-drug-sensitiveresistant-cells-optimizes-dosing-strategies-for-egfr-mutant-nsclc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.lungcancergroup.de\/en\/"},{"@type":"ListItem","position":2,"name":"Projects","item":"https:\/\/www.lungcancergroup.de\/en\/project\/"},{"@type":"ListItem","position":3,"name":"Evolutionary cancer modeling using growth kinetics of drug sensitive\/resistant cells optimizes dosing strategies for EGFR-mutant NSCLC"}]},{"@type":"WebSite","@id":"https:\/\/www.lungcancergroup.de\/en\/#website","url":"https:\/\/www.lungcancergroup.de\/en\/","name":"Lung Cancer Group Cologne","description":"Lungenkrebs Studiengruppe K\u00f6ln","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.lungcancergroup.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project\/1045","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/types\/project"}],"author":[{"embeddable":true,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/comments?post=1045"}],"version-history":[{"count":0,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project\/1045\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/media?parent=1045"}],"wp:term":[{"taxonomy":"project_category","embeddable":true,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project_category?post=1045"},{"taxonomy":"project_tag","embeddable":true,"href":"https:\/\/www.lungcancergroup.de\/en\/wp-json\/wp\/v2\/project_tag?post=1045"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}